DP Technology

DP Technology, founded in 2018, is a company that pioneers the "AI for Science" research paradigm, developing solutions that apply artificial intelligence to solve challenges in scientific and industrial research and development. The company was cofounded by Weijie Sun (CEO) and Linfeng Zhang. The founders aim to reduce the high costs associated with bringing products, like new pharmaceuticals, to market by using AI to analyze data and shorten development timelines. DP Technology has secured significant funding through multiple rounds, including a $100 million round in August 2023 to expand its platforms.

The company's core offering is the "DP Particle Universe," a collection of pre-trained large science models that connect foundational research with industrial applications. This ecosystem is comprised of a suite of software platforms catering to various industries. Clients include pharmaceutical companies, battery designers, and materials science organizations. The business model centers on providing these specialized software solutions to industrial and academic clients to accelerate their R&D processes.

DP Technology's product suite includes: Hermite®, a computational drug design platform that integrates AI and physics-based modeling for preclinical drug discovery, from hit discovery to lead optimization ; RiDYMO®, a platform focused on discovering and optimizing drug candidates for traditionally "undruggable" targets by exploring small molecules and macrocycles ; Piloteye®, a battery design automation platform ; and Bohrium®, a scientific research space that provides a foundation for the other platforms. These tools are designed to be user-friendly, often featuring web-based interfaces and visualization tools to make complex computational science accessible to researchers at all skill levels.

Keywords: AI for Science, computational drug design, molecular simulation, scientific research software, materials discovery, battery design automation, preclinical drug discovery, lead optimization, hit discovery, large science models, computational chemistry, high-performance computing, drug development, materials science, life sciences, energy technology, R&D automation, deep learning, molecular modeling, generative AI